DXCM Income Statement

Dexcom Inc - Revenue, Expenses & Profit Analysis

Stock Price

$73.43

Market Cap

$28.64B

P/E Ratio

35.1

EPS (TTM)

$2.09

Most Recent Quarter

Period: 2024-12-31(2024-12-31)

Revenue

Total sales from operations

$4.03B

+11.3% YoY

Net Income

Bottom line profit

$576.20M

Margin: 0.2%

Earnings Per Share (Diluted)

Net income per share

$1.42

Profitability Metrics

Gross Margin

60.1%

Operating Margin

0.3%

Net Margin

0.2%

Return on Equity

0.3%

Historical Income Statements

PeriodRevenueGross ProfitOperating IncomeNet IncomeEPS
2024-12-31$4.03B--$576.20M$1.42
2023-12-31$3.62B--$541.50M$1.30
2022-12-31$2.91B--$341.20M$0.82
2021-12-31$2.45B--$216.90M$0.53
2020-12-31$1.93B--$549.70M$1.33

View Complete Financial Analysis

Full income statements, balance sheets, cash flows, and AI-powered insights

Open Full Analysis

Frequently Asked Questions

What is DXCM's revenue?

DXCM's most recent quarterly revenue was $4.03B, representing a growth of 11.3% year-over-year.

Is DXCM profitable?

DXCM reported a profit of $576.20M in the most recent quarter. The net profit margin is 0.2%.

What is DXCM's operating income?

Operating income data is available in the income statement.

What is DXCM's earnings per share (EPS)?

DXCM reported diluted earnings per share of $1.42 in the most recent quarter.

What is DXCM's gross profit margin?

DXCM has a gross profit margin of 60.1%, indicating the profitability of core operations before operating expenses.

Explore Categories